✦ LIBER ✦
Sorafenib as third- or fourth-line treatment of advanced gastrointestinal stromal tumour and pretreatment including both imatinib and sunitinib, and nilotinib: A retrospective analysis
✍ Scribed by Montemurro, M.; Gelderblom, H.; Bitz, U.; Schütte, J.; Blay, J.Y.; Joensuu, H.; Trent, J.; Bauer, S.; Rutkowski, P.; Duffaud, F.; Pink, D.
- Book ID
- 120277085
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 254 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.